To further clarify the influence of FOXO3 on IFITM3-mediated GC progression and therapeutic resistance, the characteristics of CSCs in IFITM3-overexpressing GC cells following FOXO3-A3 overexpression were determined. The gene discussed is IFITM3; the disease is gastric cancer.